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Abstract
Following spinal cord injury (SCI) a series of anatomical and functional plastic changes
occur in the spinal cord, including reorganization of the spinal neuronal network, alteration
of properties of interneurons and motoneurons as well as up- or down-regulation of
different neurotransmitter receptors. In mammalian spinal cord, one of the important
neurotransmitters, serotonin (5-HT), plays an essential role in modulating sensory, motor
and autonomic functions. Following SCI, especially complete spinal cord lesion, the
descending supply of 5-HT is lost. As a consequence different 5-HT receptors undergo
variant degrees of plastic changes.
In this chapter I have systematically reviewed the distribution of different 5-HT receptors
in the spinal cord and their plastic changes following SCI where applicable. In addition,
the plastic changes of 5-HT supplying system in reaction to SCI have also been re‐
viewed. These results indicate that 5-HT receptors are important factors not only for
modulation of normal motor function, their plastic changes are also critical for motor
functional recovery and, quite often, for the development of certain pathological states
after SCI. Pharmacological and/or genetic intervention of selected 5-HT receptors and/or
intrinsic 5-HT producing system in the spinal cord may pave new ways for the restora‐
tion of motor functions after SCI.
Keywords: monoamine, monoamine receptor, spinal cord, motor control, intraspinal
5-HT cell
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1. Introduction
Spinal cord injury (SCI) is a devastating condition with an incidence of 10–83 per million people
per year worldwide according to statistical data from different countries [1]. It leads to an
extensive and usually irreversible loss of sensory functions, voluntary motor control, and
autonomic functions below injury level. A variety of primary and secondary complications
occur depending on the severity of the injury and time course of its development. These
symptoms may involve different systems, manifesting as, e.g., paralysis, spasticity, neuro‐
pathic pain, pulmonary and cardiovascular problems, osteoporosis, anemia, pressure ulcers,
bladder and bowel problems, and sexual dysfunction [2–8]. Currently, there is no cure for SCI
and thus improving quality of life, such as restoration of partial motor and sensory functions,
has become a priority for setting up the treatment strategy. The primary cause of these
problems is the loss of both descending and ascending projecting pathways in the spinal cord.
The descending pathways include direct motor-initiating pathways, such as cortical spinal
tracts, and modulatory pathways, such as serotonergic, dopaminergic, and noradrenergic
pathways. These monoaminergic systems are so important that in either acute or chronic SCI
direct stimulation of the receptors of these monoamines with drugs could regain locomotor
activity in animals [9–17]. Thus, restoring the function of monoaminergic systems has become
a key strategy to restore motor function and ameliorate secondary symptoms [18–23].
So far a great number of studies have been focusing on the serotonergic system in SCI. In the
mammalian spinal cord, serotonin (5-HT) originates mainly in the raphe nuclei of the brain‐
stem and plays an important role in modulating sensory, motor, and autonomic function [24–
27]. Following SCI, especially complete spinal cord lesion, the descending supply of 5-HT is
lost and as a consequence different 5-HT receptors undergo variant degrees of plastic changes
[22, 28–36]. In addition, a potential intraspinal 5-HT-producing system in the spinal cord, i.e.,
aromatic L-amino acid decarboxylase (AADC) cells, also undergoes plastic changes to increase
their potency to produce 5-HT from its precursor [37–40]. Although these plastic changes may
induce pathological symptoms such as spasticity and chronic central pain [34, 41, 42], they are
essential for spinal function recovery (for review see [43–45]). In this chapter, I will make a
systematic review according to up-to-date literature related to the distribution and plastic
changes of 5-HT receptors in the spinal cord in normal or SCI states with a note on the
intraspinal 5-HT-producing cells.
2. 5-HT in the spinal cord in health
In mammals, including humans, 5-HT axons in the spinal cord almost exclusively originate
from the brainstem raphe nuclei [46–49]. Their terminals are distributed in all parts of the gray
matter at all levels of the spinal cord [50, 51]. The cell bodies with descending 5-HT projec‐
tions are located in the caudal part of the raphe nuclei, which include the raphe magnus, raphe
obscurus, raphe pallidus, ventral lateral medulla, and the area postrema [52]. In the spinal
cord, 5-HT projecting fibers descend in the white matter through two different routes: one with
Recovery of Motor Function Following Spinal Cord Injury96
fibers from the raphe magnus in the dorsal part of the lateral funiculus which terminates
mainly in the dorsal horn, and the other with fibers from raphe obscurus and raphe pallidus
in the ventral funiculus which terminates mainly in the ventral horn and the intermediate zone.
In addition to the descending projecting system, there are indeed 5-HT neurons in the spinal
cord although in normal states their contribution of 5-HT can be ignored. So far a small number
of intraspinal 5-HT neurons have been reported in macaque monkey (ca. 150 cells per
monkey [53]), rat (3–9 cells per rat [54, 55]), and mouse [51]. In the rat spinal cord, 5-HT cells
were distributed in different parts of the spinal cord with the exception of cervical segments;
in the monkey spinal cord most of the cells were observed in the cervical segments with a small
number in other segments; whereas in the mouse spinal cord they were exclusively located in
the sacral segments. In the rat spinal cord, the 5-HT cells were found to be located in lami‐
nae VII and X in the gray matter, whereas in monkey and mouse spinal cord they were
exclusively found in lamina X.
Serotonin in the spinal cord plays an important role in sensory information processing, motor
control, and autonomic function. Traditionally, it is hypothesized that 5-HT in the spinal cord
exerts its effects by inhibiting sensory systems and facilitating motor systems [56]. However,
now it is known that the effects of 5-HT are very complicated both in sensory and motor
aspects. In sensory aspect, 5-HT not only has antinociceptive but also pronociceptive effects
(e.g., [57, 58]). In motor aspect, except for facilitating motor output, 5-HT also inhibits motor
behavior (e.g., [59, 60]). The different functions that 5-HT exert at different circumstances
depend on many factors, such as the brainstem origins of the descending projections, the
termination localizations of these fibers in the spinal cord, and the activation states of its
different receptors.
3. 5-HT receptors in the spinal cord in health
The diverse functions of 5-HT in the spinal cord are achieved through the activation of
different 5-HT receptors. As seen in Table 1, seven families (or types) and at least 14 subfa‐
milies (or subtypes) of 5-HT receptors have been identified so far [61]. In these seven fami‐
lies, with exception of 5-HT3 receptors that are ligand-gated ion channels, all other families
are G protein-coupled receptors [62]. To better understand the diversity of 5-HT functions, it
is fundamentally important to have the knowledge of the anatomical localizations of differ‐
ent 5-HT receptors in the spinal cord. A majority, though not all, of 5-HT receptor subfami‐
lies have been found to be expressed in the spinal cord (for reviews see [63, 64]). Here, I will
make a systematic review of these receptors in terms of their cellular as well as subcellular
localizations in the spinal cord based on available data. One should keep in mind that due to
the existence of a great number of splices and editing variants for several 5-HT receptors, a
greater degree of operational diversity could be expected, though this issue is not the focus of
the present review.
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Receptor
family
(year of
molecular
gene
clone)*
Receptor
subfamily
(year of
molecular
gene clone)*
Expression in
the spinal cord
Functions at
normal states
Expression
changes
following
SCI
Functions at
SCI states
5-HT1 1A (1987) Primary afferent
fibers in dorsal
horn [66]; neuronal
somata in
different
laminae of
gray matter
[31,69];
axon initial
segments [31,71];
Antinociception [73,76];
pronociception [77];
increases
motoneuron
excitability [60];
induces central
fatigue [81]
Upregulation
at least to
30 days after
SCI [28,31]
Promotes motor
functional
recovery
[13,14,172]
1B (1992) Primary afferent
fibers in
dorsal horn
[83]; neuronal
somata at
least in
intermediate
zone [38]
Antinociception [72];
autoreceptor [89];
inhibits activity
of AADC cells
[38]
-- Inhibits mono-
and polysynaptic
reflexes
[99,174]
1D (1991) Primary afferent
fibers in
dorsal horn
[92]; gamma
motoneurons
in ventral
horn [94]
Antinociception, [93];
modulates
proprioceptive
circuits
[94]
-- Inhibits
polysynaptic
reflex [95]??
1E (1992) -- -- -- --
1F (1993) Substantia
gelatinosa
of spinal
dorsal horn
[98]
Antinociception
[101,102]??
-- Inhibits
polysynaptic
reflex [99]??
5-HT2 2A (1988) Different laminae
of the spinal
gray matter
but largely in
the superficial
dorsal horn
and lamina IX
Pronociceptive [57,112];
antinociceptive [115];
excites motoneuron
[117]; facilitates
micturition reflex
[119]; facilitates
sexual behavior
Upregulation
[32,33,35]
Locomotor
functional recovery
[12,14,43]; 5-HT
supersensitivity
and muscle spasm
[42]
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Receptor
family
(year of
molecular
gene
clone)*
Receptor
subfamily
(year of
molecular
gene clone)*
Expression in
the spinal cord
Functions at
normal states
Expression
changes
following
SCI
Functions at
SCI states
[104,107,108] [120,121]
2B (1992) Dorsal horn
(probably primary
afferent fibers) [109]
Pronociception
[109,124,126]
Constitutive
activation [182]
Motoneuron
hyperexcitability
and muscle spasm
[182]
2C (1988)
(Named 1C
before 1993)
Different
laminae of the
spinal gray
matter [36,104,107]
Pronociception
[57,112];
antinociception
[96,115,133];
induces long-lasting
amplification of
spinal reflexes
[73,134]; inhibits
micturition reflex
[127,138]
Constitutive
activation [34,182];
upregulation
[22,36,177]
Motor functional
recovery [34,182];
5-HT supersensitivity,
motoneuron
hyperexcitability,
and muscle spasm
[34,42,182]
5-HT3 3A (1991)
3B (1999)
3C (2003)
3D (2003)
3E (2003)
[62,139]
Different laminae
of the spinal
gray matter
[107,142]
Antinociception [145,146];
pronociception [149];
mediates tail-flick
reflexes [117];
inhibits bladder
function [152]
-- Promotes motor
function recovery [151]
5-HT4 (1995) Ventral horn,
some sympathetic
neurons [153]
Pronociception [154] -- --
5-HT5 5A (1994) Dorsal horn,
intermediate
lateral nucleus,
and Onuf’s
nucleus [110,156]
Antinociception [58,157];
autonomic and
micturition control
[156]
-- --
5B (1993) -- -- -- --
5-HT6 (1993) Different laminae
of the spinal
gray matter [159]
Pronociception [160] -- --
5-HT7 (1993) Dorsal horn,
intermediate
zone, and
ventral horn
Pronociception [164–166];
promotes locomotion
Promotes
locomotor
functional
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Receptor
family
(year of
molecular
gene
clone)*
Receptor
subfamily
(year of
molecular
gene clone)*
Expression in
the spinal cord
Functions at
normal states
Expression
changes
following
SCI
Functions at
SCI states
with a dorsoventral
density gradient
[16,162]
[16,167,169] recovery [43,172]
* Year of molecular gene clone is based on Wikipedia (https://en.wikipedia.org/wiki/5HT_receptor) except 5-HT3
receptors; --: no data available; ??: data not conclusive.
Table 1. 5-HT receptors in the spinal cord and plastic changes following SCI.
3.1. 5-HT1 receptors
As listed in Table 1, 5-HT1 receptors include five subfamilies: 1A, 1B, 1D, 1E, and 1F. Although
all of these receptors have been detected in the brain by different techniques [65], there is no
report to my knowledge demonstrating the expression of 5-HT1E receptors in the spinal cord.
In addition, the evidence of the existence of 5-HT1F in the spinal cord is mainly from physio‐
logical experiments. Nonetheless, I will describe 5-HT1A, 1B, 1D, and 1F in the spinal cord
according to the available data.
5-HT1A receptors: Data from both autoradiographic (radioligand binding) and immunohisto‐
chemical experiments have demonstrated the presence of 5-HT1A receptors in different
regions of the spinal gray matter across different spinal segments in rats [31, 66–69]. 5-HT1A
receptor binding sites were predominantly seen in the dorsal horn especially laminae I and
II [67], where they were partly located in the primary afferent fibers [66]. In autoradiograph‐
ic images, it is difficult to identify the components located in cell bodies; however, with
immunohistochemistry with a 5-HT1A antibody generated from an intracellular epitope, it
was clear that 5-HT1A receptors were expressed in cell bodies in the spinal cord [31]. The
immunolabeled cell bodies were located in different spinal regions in the gray matter including
the dorsal horn, intermediate zone, and ventral horn [31, 69, 70]. In addition, using a differ‐
ent 5-HT1A antibody generated from an extracellular epitope, the receptors were also shown
to be present in the axon hillock [31, 71]. There are no studies to investigate 5-HT1A receptor
localization at an ultrastructural level and therefore no data available for their subcellular
distribution.
It is commonly believed that 5-HT1A receptors exert an inhibitory effect in sensory informa‐
tion transmission including nociception in the spinal dorsal horn (e.g., [72–76]). For example,
in mice intrathecal injection of 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)
tetralin (8-OH-DPAT) could inhibit the tail-flicks induced by noxious radiant heat [72]. In
neonatal rat spinal cord in vitro experiments, Hochman et al. [73] showed that 8-OH-DPAT
depressed evoked excitatory postsynaptic potentials (EPSPs) in the deep dorsal horn neu‐
rons, whereas 5-HT1A receptor antagonist WAY-100635 (N-[2-[4-(2-methoxyphenyl)-1-
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piperazinyl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide) facilitated evoked EPSPs. Data
from the same group also indicated that the activation of 5-HT1A receptors facilitated long-
term depression in the dorsal horn neurons. However, the effects of 5-HT1A receptors in the
dorsal horn are not always inhibitory. For example, the activation of 5-HT1A receptors has
been reported to facilitate nociceptive [77, 78] and itch transmission [79], and to induce
spontaneous tail-flicks [80].
As 5-HT1A receptors have been found to be present both at the neuronal somata and the axon
initial segments in spinal ventral horn neurons, including motoneurons [31], it is speculated
that 5-HT1A receptors may have heterogeneous functions on motor outputs, i.e., both
excitatory and inhibitory [59, 60]. Indeed, using a turtle spinal cord, slice preparation, and
intracellular recording technique, Perrier and Cotel [60] demonstrated that the activation of 5-
HT1A receptors by 8-OH-DPAT induced an increased excitability in a large fraction (9/11) of
sampled motoneurons; whereas in a small fraction of motoneurons (2/11) 8-OH-DPAT gave a
hyperpolarizing effect. Subsequent data from the same research group have demonstrated that
the inhibitory effect was due to the activation of extrasynaptic 5-HT1A receptors located at the
axon initial segments, a mechanism supposed to underlie central fatigue [81, 82].
5-HT1B receptors: To the best of my knowledge, there are no systematic immunohistochemi‐
cal studies on the distribution of 5-HT1B receptors in the spinal cord. Previous studies using
autoradiography have demonstrated that 5-HT1B receptors did not have any dominant
expression region in the spinal gray matter although the intermediate zone seemed to dwell
slightly higher labeled profiles [67, 68]. Although it is difficult to differentiate labeled cell
bodies from nerve fibers with autoradiography, results from studies using other methods
including lesion, pharmacology, and reverse transcription polymerase chain reaction (RT-
PCT) indicated the existence of this receptor subfamily both at presynaptic (primary afferent
fibers) [83] and postsynaptic locations (motoneurons) [84, 85]. Recently by using immunohis‐
tochemistry, Wienecke et al. [38] have found that 5-HT1B receptors were indeed expressed in
the cell bodies at least in the intermediate zone in the rat spinal cord.
Similar to 5-HT1A receptors, a major role of 5-HT1B receptors is inhibition in sensory
transmission, especially nociception [72, 86, 87]. For example, Eide et al. [72] showed that in
mice intrathecal injection of 5-HT1B receptor antagonist RU-24969 (5-methoxy-3(1,2,3,6-
tetrahydropyridin-4-yl)-1H-indole) induced a significant increase of tail-flick latencies.
Another role of 5-HT1B receptors is to inhibit the release of 5-HT from its fibers via autore‐
ceptor mechanism. Although both 5-HT1A and 1B receptors have been demonstrated to be
autoreceptors in the brain, in the spinal cord it is most likely that 5-HT1B receptors play a more
important role than 5-HT1A receptors in controlling the release of 5-HT from 5-HT fiber
terminals [88–90]. Thus, Brown et al. [89] using rat spinal cord synaptosomes preparation
showed that the 5-HT1B receptor agonists 1-(m-trifluoromethylphenyl)piperazine and 1-(m-
chlorophenyl) piperazine concentration-dependently decreased [3H]5-HT release. In addi‐
tion, 5-HT1B receptors could also inhibit the production of 5-HT from AADC cells in the spinal
cord through feed-forward mechanism so that the AADC cells do not produce 5-HT in normal
physiological states [38]. Another function of 5-HT1B receptors, as noted in mice, is to delay
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the maturation of γ-aminobutyric acid (GABA) phenotype in spinal cord during its develop‐
ment [91].
5-HT1D receptors: Data concerning the anatomical localization of 5-HT1D receptors in the
spinal cord are relatively poor. The available data indicate that 5-HT1D receptors exist both in
the dorsal and the ventral horn. Using immunohistochemistry, 5-HT1D receptors were found
to be expressed in the primary afferent fibers in the superficial dorsal horn of the rat spinal
cord [92, 93]. At the ultrastructural level, 5-HT1D receptors in the spinal cord dorsal horn were
found to be localized exclusively within dense core vesicles of synaptic terminals and not the
plasma membrane [92]. Using in situ hybridization and transgenic mouse model, Enjin et al.
[94] found that 5-HT1D receptors were specifically expressed in γ motoneurons in the ventral
horn as well as in some proprioceptive sensory neurons in different spinal regions which were
coexpressed with parvalbumin (used as a proprioceptive neuronal marker in the study).
The available data indicate an effect of 5-HT1D receptors in the suppression of sensory,
especially nociceptive, information transmission [58, 93, 95]. However, different results were
also present. For example, in a formalin-induced hindpaw pain model, Jeong et al. [96] showed
that the 5-HT1D receptor agonist GR-46611 (3-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-(4-
methoxybenzyl)acrylamide) did not suppress the formalin-induced flinching responses and
the 5-HT1D receptor antagonist BRL-15572 (3-(4-(4-chlorophenyl)piperazin-1-yl)-1,1-diphen‐
yl-2-propanol) failed to reverse the antinociceptive effects of 5-HT. Other functions of 5-HT1D
receptors include, e.g., depressing the spinal monosynaptic reflex induced by endogenously
released 5-HT [97], and shaping proprioceptive circuits to receive and relay accurate sensory
information in the spinal cord motor network [94]. In addition, since 5-HT1D receptors were
expressed in γ, but not α, motoneurons, they could be used as a marker to identify γ moto‐
neurons in the spinal cord [94].
5-HT1F receptors: To my knowledge, there is no systematic investigation concerning the
expression of 5-HT1F receptors in the spinal cord of any species. However, there are indeed
some pieces of evidence from studies using radioligand or physiological technique indicat‐
ing that this receptor subfamily is present in the spinal cord dorsal horn. Castro et al. [98]
used [3H]sumatriptan as a radioligand in the presence of suitable concentrations of 5-carbox‐
amidotryptamine (5-CT) to define 5-HT1F receptors in the human spinal cord, and they found
significant levels of binding sites in substantia gelatinosa in the cervical spinal cord. However,
because 5-CT is not a specific 5-HT1F agonist, the data cannot be taken as granted. Using an
in vitro sacrocaudal spinal cord preparation from spinal transected rats, Murray et al. [99]
showed that the EPSPs and associated long polysynaptic reflexes were consistently inhibited
by 5-HT1F-specific agonist LY-344864 (N-[(3R)-3-(dimethylamino)-2,3,4,9-tetrahydro-1H-
carbazol-6-yl]-4-fluorobenzamide), indicating the existence of 5-HT1F in the spinal cord.
However, the exact locations of these receptors are yet to be determined.
Due to the lack of related anatomical data, it is difficult to unveil the functions of 5-HT1F in
the spinal cord. Considering that 5-HT1F receptors are expressed in the trigeminal and spinal
dorsal root ganglia [100] and their agonists have been used to treat migraine [101, 102], it is
most likely that this receptor subfamily exerts an antinociceptive effect in spinal cord.
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3.2. 5-HT2 receptors
As listed in Table 1, 5-HT2 receptors include three subfamilies, i.e., 5-HT2A, 2B, and 2C.
Before 1993, 5-HT2C receptors were named 5-HT1C receptors [103]. By using different
experimental techniques including autoradiography, in situ hybridization, Western blot and
immunohistochemistry all these three receptor subfamilies have been detected in the spinal
cord in different species [104–109] although 5-HT2C subfamily is probably not expressed in
cat spinal cord [105]. 5-HT2A and 2C receptors are likely among the most thoroughly
investigated 5-HT receptors in the spinal cord due to their important functions in both sensory
information processing and motor control.
5-HT2A receptors: Using various techniques, the existence of 5-HT2A receptors has been
confirmed at both mRNA and protein level in the spinal cord of different species [104–108,
110]. By using polymerase chain reaction (PCR) together with Southern hybridization
technique, Helton et al. [105] showed that spinal cord tissues from rat, cat, monkey, and human
contained 5-HT2A receptor mRNAs. By using in situ hybridization, Pompeiano et al. [104]
showed that 5-HT2A receptor mRNAs were present at intermediate density in the ventral horn.
This distribution pattern has been confirmed with immunohistochemistry [106, 108]. Doly et
al. [108] systematically investigated the distribution of 5-HT2A receptor immunoreactivity in
rat spinal cord and the results indicated that 5-HT2A receptors were distributed in all the spinal
segments with a similar immunolabeling pattern. The most prominent labeling was found in
lamina IX, where many, but not all, motoneurons were labeled. At lumbar five to six level, 5-
HT2A receptors were densely expressed in Onuf’s nucleus that contains the motoneurons
innervating pelvic striated muscles controlling sexual behavior and micturition [110]. Another
region with dense immunolabeling was lamina II. The remaining laminae of the gray matter
displayed a weak to moderate labeling. Doly et al. [108] also examined the subcellular
localization of 5-HT2A receptors in laminae II and IX and they demonstrated that most
immunolabeled profiles were postsynaptic, i.e., dendrites and cell somata, although a small
number of axons and axon terminals were also labeled. The immunoreactive product was
localized mainly on the plasma membrane where synaptic specifications were lacking.
The localization of 5-HT2A receptors in the neurons in both the spinal dorsal and ventral horn
endows their functions in both sensory information transmission and motor control. For the
sensory information modulation, evidence to date largely favors in their pronociceptive role
[57, 111–114]. For example, Kjørsvik et al. [112] showed that in formalin-induced pain model,
intrathecal injection of DOI ((±)-2,5-dimethoxy-4-iodoamphetamine hydrochloride), a 5-
HT2A/2C receptor agonist, augmented nociceptive response in rats. This effect could be
completely abolished when ketanserin (a 5-HT-2A receptor antagonist) was coadministrated.
Rahman et al. [57] investigated the effects of DOI, ketanserin, and ritanserin (another 5-HT2A/
2C antagonist) on the evoked responses of dorsal horn neurons to electrical, mechanical, and
thermal stimulation, and found that the activation of 5-HT2A receptors facilitated the spinal
nociceptive transmission under normal physiological states. However, there is also evidence
indicating that 5-HT2A receptors exert an antinociceptive effect [115, 116]. For example, using
a rat spinal cord slice preparation Xie et al. [115] found that bath application of 5-HT in‐
creased the frequency of spontaneous inhibitory postsynaptic currents in GABAergic and
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glycinergic neurons in substantia gelatinosa. TCB-2 (4-bromo-3,6-dimethoxybenzocyclobut‐
en-1-yl)methylamine hydrobromide), a 5-HT2A receptor agonist, could mimic the 5-HT effect,
and ketanserin could partially inhibit the effect of 5-HT and completely inhibit the effect of
TCB-2.
It is not surprising that 5-HT2A receptors play a significant role in motor control consider‐
ing their intensive expression in ventral horn motoneurons. Indeed, direct stimulation of 5-
HT2 receptors in motoneurons in vivo with selective 5-HT2 receptor agonist DOI or DOM (2,5-
dimethoxy-alpha,4-dimethylbenzene ethamine hydrochloride) produced dose-related back
muscle contractions and wet dog shakes which could be markedly attenuated by ritanserin,
ketanserin, or mianserin, suggesting an effect from 5-HT2A receptors [117]. Their direct
facilitating effect on spinal motoneurons was also evidenced by application of DOI in rat spinal
cord in vitro experiments [118]. In addition, pharmacological experiments showed that 5-
HT2A receptor activation facilitated micturition reflex and activated the external urethral
sphincter in female rats [119], whereas in both male and female rats 5-HT2A receptors seemed
to involve sexual behavior [120, 121].
5-HT2B receptors: In comparison with 5-HT2A and 5-HT2C, 5-HT2B receptors in the spinal cord
have been less investigated and the available data are inconsistent. Using in situ hybridiza‐
tion expression of 5-HT2B receptors was not found in rat spinal cord and even brain [104].
However, using several other techniques, the receptors have been detected in the spinal cord.
Thus, using reverse transcription polymerase chain reaction (RT-PCR) 5-HT2B receptor
mRNAs have been detected in spinal cord tissue in many different species including rat, cat,
monkey, and human [105]. Using microarray global gene expression technique [122] and
immunohistochemistry [123], 5-HT2B receptors have been detected in the rat spinal cord
motoneurons. In addition, using Western blot it was shown that the receptor proteins were
also present in the dorsal part of the spinal cord [109]. Considering that with Western blot and
immunohistochemistry 5-HT2B receptors have been demonstrated to be expressed in the
dorsal root ganglia [109, 124], their expression in the spinal dorsal horn is likely originating
from the primary afferent fibers from the dorsal root ganglia, although it cannot be excluded
that they might be also expressed in neuronal somata (e.g., [125]).
It is presumable that 5-HT2B receptors are largely related with sensory information transmis‐
sion considering their localization in dorsal root ganglia and dorsal horn. Thus, evidence from
a few studies related to 5-HT2B receptor functions in the spinal cord favors that the recep‐
tors are responsible for facilitating mechanical hyperalgesia, tactile allodynia, and nocicep‐
tion [109, 124, 126]. Studies concerning the receptors’ motor function are rare. One study
showed that 5-HT2B receptors likely increased urethral smooth muscle tone since the 5-HT2B
receptor antagonist RS-127445 (3-(4-(4-chlorophenyl)piperazin-1-yl)-1,1-diphenyl-2-propa‐
nol) blocked increase in urethral pressure in female rats [127]. In frog, the activation of 5-HT2B
receptors by α-methey-5-HT (a 5-HT2B receptor agonist) facilitates N-methyl-D-aspartate
(NMDA)-induced depolarization of motoneurons [128]. In addition, 5-HT2B receptors seemed
to modulate respiratory activity in rats [123].
5-HT2C receptors: 5-HT2C receptor mRNAs and proteins were widely distributed in differ‐
ent laminae of the spinal gray matter including motoneurons as demonstrated by different
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experimental methods, such as PCR [105], autoradiography [68, 129], in situ hybridization
[104, 107], and immunohistochemistry [36, 130–132]. Using PCR combined with Southern
hybridization 5-HT2C receptor mRNAs were detected in spinal cord tissue from rat, mon‐
key, and human, but not in cat spinal cord [105]. By using in situ hybridization, Fonseca et al.
[107] showed that 5-HT2C receptor mRNAs were present at high levels in most parts of the
spinal gray matter, except lamina II. Using immunohistochemistry, Ren et al. [36] have
investigated 5-HT2C receptor expression in both normal and spinalized rats and the results
showed that 5-HT2C receptors were widely distributed in different regions of the spinal gray
matter (except lamina II) and were predominantly located in the neuronal somata and their
dendrites although they also seemed to be present in axonal fibers in the superficial dorsal
horn. Thus, the data from in situ hybridization and immunohistochemistry fit very well for
this receptor subfamily.
The wide distribution of 5-HT2C receptors in different laminae of the spinal cord endows the
receptors’ role both in sensory information transmission and motor control. For the sensory
information transmission available data point to that 5-HT2C receptors play roles both in
pronociception [57, 112] and antinociception [96, 115, 133]. For their role on pronociception,
refer to the part concerning 5-HT2A receptors since most studies used DOI (a common agonist
for 5-HT2A and 2C receptors) to stimulate and ketanserin to inhibit the receptors in re‐
sponse to different nociceptive stimulations. However, because ketanserin is mainly a 5-HT2A
receptor antagonist some researchers argued that the pronociception effect should prefera‐
bly attribute to 2-HT2A than 2C receptors. Their effects on antinociception seem to be
adequately evidenced. For instance, in one study Jeong et al. [96] showed that in formalin-
induced pain model 5-HT2C receptor specific antagonist D-MC (N-ormethylclozapine/8-
chloro-11-(1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine) could block the suppression effect
of 5-HT, whereas 5-HT2C receptor specific agonist MK-212 (6-chloro-2-(1-piperazin‐
yl)pyrazine hydrochloride) could suppress the formalin response. In another study, Xie et al.
[115] showed that a 5-HT2C receptor agonist WAY-161503 (8,9-dichloro-2,3,4,4a-tetrahy‐
dro-1H-pyrazino[1,2-a]quinoxalin-5(6H)) mimicked the 5-HT antinociceptive effect in dorsal
horn neurons and this effect could be blocked by a 5-HT2C receptor antagonist, N-desmethyl‐
clozapine.
In motor control, one of the functions of 5-HT2C receptors is the induction of a long-lasting
amplification of spinal reflex [73, 134–136]. Machacek et al. [134] showed that, in an in vitro
neonatal rat spinal cord preparation, superfusion of 5-HT depressed reflex responses record‐
ed in the ventral roots which was induced by electrical stimulation of primary afferents.
However, following 5-HT washout, a long-lasting reflex facilitation was observed. Further
pharmacological analysis indicated that it was the activation of 5-HT2C but not 5-HT2A
receptors that was required for this long-lasting reflex. Although 5-HT2C receptors play a
major role in long-term motor reflexes, they also play an inhibitory role in some physiologi‐
cal states. For example, in mice, when activated by DOI, 5-HT2C receptors inhibited the
locomotor activity which opposed the effects of 5-HT2A receptors [137]. In addition, 5-HT2C
receptors were also demonstrated to inhibit the micturition reflex [119, 127, 138]. Thus, Conlon
et al. [138] showed that, in guinea pigs, Ro-600175 ((αS)-6-chloro-5-fluoro-α-methyl-1H-
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indole-1-ethanamine fumarate), a 5-HT2C receptor agonist, increased peak urethral pressure
in a dose-dependent manner. This effect was reversed by a selective 5-HT2C receptor
antagonist SB-242084 (6-chloro-2,3-dihydro-5-methyl-N-[6-[(2-methyl-3-pyridinyl)oxy]-3-
pyridinyl]-1H-indole-1-carboxyamide) but not a 5-HT2A or 2B receptor antagonist. Similar
results were also observed in rats [119, 127]. Clinically, duloxetine, a serotonin-norepinephr‐
ine reuptake inhibitor, has been used to treat stress urinary incontinence. One possible
mechanism for this effect may be the activation of 5-HT2C receptors in motoneurons in Onuf's
nucleus, which leads to an increased activity of pudendal motor neurons and a subsequent
increase in the strength of urethral sphincter contractions.
3.3. 5-HT3 receptors
Although genes encoding the molecular structures of five different 5-HT3 receptor subfami‐
lies (A–E) have been cloned, it is demonstrated so far that only the 5-HT3A subfamily is
functional in homomeric form, and all other subfamilies require coassembling with 5-HT3A
as functional heteromers [62, 139]. Therefore, here 5-HT3 receptors will be described togeth‐
er as one receptor unity. In the spinal cord, 5-HT3 receptors in the beginning were detected
mainly in the dorsal horn with autoradiography and immunohistochemistry in rats and
humans [140, 141]. Later by using in situ hybridization and immunohistochemistry, they were
found to be expressed in different laminae across the spinal gray matter [107, 142]. By using
immunohistochemistry, Morales et al. [142] observed labeled cell bodies in the dorsal horn
among the densely labeled fiber terminals. In the ventral horn, large neurons, likely moto‐
neurons, were densely labeled. By using in situ hybridization, Fonseca et al. [107] found that
5-HT3 receptor mRNAs were expressed in different laminae in the rat spinal cord with very
low levels in the dorsal horn, slightly higher levels in laminae VI through X and the highest
level in lamina IX. Maxwell et al. [143] have studied the ultrastructure of 5-HT3 immunola‐
beled profiles in the dorsal horn of the rat spinal cord. They found that 5-HT3-immunoposi‐
tive terminals invariably formed asymmetric synaptic junctions with dendritic profiles and
often contained a mixture of granular and agranular vesicles. Immunoreactive cells were found
to contain intense patches of reaction product within their cytoplasm. Although there are no
data available regarding the subcellular morphology of 5-HT3 receptors in the ventral horn
neurons, from the light microscopic data, it can be concluded that the receptor immunoreac‐
tive product was located at least in the cytoplasm [142].
It has long been known that 5-HT3 receptors modulate spinal nociceptive reflexes [144]. A
large part of literature demonstrated a role of 5-HT3 receptors in antinociception in the spinal
cord (e.g., [145, 146]). This is likely due to, for instance, that the receptors interact with
inhibitory interneurons such as GABA interneurons in the dorsal horn [147]. However, there
are also data indicated that 5-HT3 receptors have a pronociceptive effect. For example, Guo et
al. [148] showed that when the spinal 5-HT3 receptors were activated by intrathecal injection
of a selective 5-HT3 receptor agonist SR-57227 (1-(6-chloropyridin-2-yl)piperidin-4-amine)
spinal glial hyperactivity, neuronal hyperexcitability, and pain hypersensitivity were in‐
duced in rats. These diverse effects could be explained by, e.g., the expression of 5-HT3
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receptors in different neuronal components and/or the different effects of assemblies formed
from different receptor subfamilies [149, 150].
Although 5-HT3 receptors are expressed in the ventral horn neurons data concerning their
motor functions are scarce. A study by Guertin and Steuer [151] showed that in hindlimb
paralyzed mice 5-HT3 receptor agonist SR-57227 could produce hindlimb movements
although with a low score. This result indicates that 5-HT3 receptors might also modulate
spinal motoneuron activity in normal states. In addition, the activation of 5-HT3 receptors by 2-
methyl-5-HT, another 5-HT3 receptor agonist, could induce sideward tail-flick reflex in rats
[117], which might likely involve both sensory and motor components in the spinal cord.
Further, 5-HT3 receptors have been reported to inhibit micturition in cats in both normal and
spinalized situation [152].
3.4. 5-HT4 receptors
Data concerning 5-HT4 receptors in the spinal cord are scarce. As far as I know, so far only one
article reported the expression of 5-HT4 receptors in the spinal cord [153]. Using immunohis‐
tochemistry, Suwa et al. [153] investigated 5-HT4 receptor cell distribution in the brain and
spinal cord in juvenile rats and found a high density of immunostained neurons in the ventral
horn of the spinal cord. In addition, several sympathetic neurons were also seen to be
immunopositive.
Similarly, studies about the functions of 5-HT4 receptors in the spinal cord are also rare. Using
pharmacological method, Godínez-Chaparro et al. [154] showed that 5-HT in the spinal cord
promotes the development and maintenance of secondary allodynia and hyperalgesia caused
by formalin stimulation via the activation of 5-HT4/6/7 receptors. Considering the anatomi‐
cal distribution of 5-HT4 receptors in the spinal cord, they should also play a role in some
motor functions. Whether this is the case needs to be investigated further.
3.5. 5-HT5 receptors
The 5-HT5 receptor family comprises two members: 5-HT5A and 5-HT5B. Although 5-HT5B
receptors have been found in some structures in rat and mouse brain, they are not expressed
in humans [155]. Therefore, I will only describe the 5-HT5A receptors in this chapter.
5-HT5A receptors were first identified in the rat spinal cord by Doly et al. [156]. They showed
that in the rat spinal cord, 5-HT5A receptors were expressed with high density in the super‐
ficial dorsal horn (laminae I and II) especially in lamina II. In addition, they were also expressed
in other regions including the intermediolateral nucleus in the thoracolumbar region and
Onuf’s nucleus in lumbosacral region. Ventral horn motoneurons in different regions were
weakly labeled. Subcellularly, the receptors were found both in the cytoplasm and on the cell
membrane of neuronal somata and dendrites. In the cytoplasm, they were associated with
Golgi apparatus, rough endoplasmic reticulum, and vesicles. On the membrane, they were
exclusively located on the postsynaptic density that was in clear contrast with the subcellu‐
lar localization of 5-HT2A receptors [108, 110].
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According to their locations in the spinal cord, it is speculated that 5-HT5A receptors are related
to spinal modulation of pain, autonomic function, and control of micturition. Indeed, data from
recent pharmacological studies have demonstrated that 5-HT-induced antinociceptive effect
was mediated by spinal 5-HT5A receptors in several pain models, such as that induced by
formalin, capsaicin, or acetic acid [58, 157]. For example, injection of 5-HT or 5-CT (an agonist
of 5-HT5A receptors) could dose-dependently prevent nociception induced by formalin [157].
However, the speculated effects of the receptors on autonomic function and control of
micturition yet need to be demonstrated.
3.6. 5-HT6 receptors
Using RT-PCR, Gérard et al. [158] discovered the existence of 5-HT6 receptor mRNAs at a
moderate level in the rat spinal cord. Later, using immunoautoradiogram, data from the same
group showed that 5-HT6 receptor immunoreactive product seemed to be present across all
laminae of the spinal gray matter with a denser labeling in the superficial dorsal horn and
lamina IX [159]. No data are available about the subcellular distribution of 5-HT6 receptors in
the spinal cord. However, according to the electron microscopic data from other brain regions
such as the striatum and the hippocampus, 5-HT6 receptors were mainly associated with
postsynaptic dendrites and no immunopositive axon terminals were found [159].
The exclusive roles of 5-HT6 receptors in the spinal cord yet remain to be elaborated. Using a
formalin pain model in rats, Castañeda-Corral et al. [160] suggested that 5-HT6 receptors play
a pronociceptive role in the spinal cord since intrathecal injection of EMD-386088 (5-chloro-2-
methyl-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole), a selective 5-HT6 receptor agonist,
enhanced formalin-induced nociception. It is unknown whether 5-HT6 receptors play any role
in motor control.
3.7. 5-HT7 receptors
As there were no specific radioligands for 5-HT7 receptors available, data concerning their
distribution in the spinal cord acquired using autoradiography had been inconclusive [161]
until 2005 when Doly et al. [162] used immunohistochemistry to study their distribution in the
rat spinal cord. Doly et al. [162] showed that in the rat lumbar spinal cord 5-HT7 receptors
were mainly located in two superficial laminae of the dorsal horn. Except in the Onuf’s nucleus
where the labeling was relatively denser, immunolabeling in the ventral horn motoneuron
region was generally weak. At subcellular level, the receptors were found in the postsynap‐
tic locations in neuronal cell bodies and dendrites as well as presynaptic locations in unmye‐
linated and thin myelinated axonal fibers. In addition, immunolabeling was also found in
astrocytes. In cats, Noga et al. [16] found that in thoracolumbar spinal cord 5-HT7-immuno‐
labeled cells spread across different laminae in the gray matter with a dorsoventral density
gradient.
Available data showed that 5-HT7 receptors exert multiple roles in modulating both sensory
and motor behavior. In sensory aspect 5-HT7 receptors have been demonstrated to exert dual
but diverse actions in nociception depending on the different situations. In healthy rats, 5-HT7
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receptor agonists exerted a pronociceptive action but in neuropathic animals they exerted an
antinociceptive action [163]. Yesilyurt et al. [164] showed that intrathecal application of
SB-269970 ((2R)-1-[(3-hydroxyphenyl)sulfonyl]-2 -(2-(4-methyl-1-piperidinyl)ethyl)pyrroli‐
dine), a 5-HT7 receptor antagonist, blocked both opioid and nonopioid type stress-induced
analgesia, and this effect was mediated by descending serotonergic pathways and the spinal
5-HT7 receptors. Several pieces of evidence have indicated that the nonopioid analgesic drug
Nefopam also took its effects via activation of 5-HT7 receptors [165, 166].
5-HT7 receptors have been demonstrated to be critical for 5-HT-induced locomotor-like
activity [16, 167–169]. Liu and Jordan [167] showed that in rats 5-HT7 receptor antagonists
blocked locomotor-like activity induced by stimulating mid-medulla region and also de‐
creased step cycle duration. These results have been verified in 5-HT7 knockout mice [169].
Considering that 5-HT7 receptor antagonists blocked locomotor-like activity when applied
only above the L3 segments [167], it is possible that they activated the central pattern genera‐
tor neurons above this level that expressed 5-HT7 receptors and responded to 5-HT stimula‐
tion. Indeed, in decerebrated cats in which locomotion was induced by electrical stimulation
of the mesencephalic locomotor region abundant c-Fos immunoreactive cells were observed
in laminae VII and VIII throughout the thoracolumbar segments [16].
4. Expression changes of different 5-HT receptors and their significance in
motor outputs following SCI
Following SCI the descending 5-HT projections are interrupted and as a consequence, a
number of 5-HT receptors undergo different degrees of plastic changes below the lesion
depending on the severity of injury, which on one hand will facilitate the re-establishment of
neuronal circuits in the spinal cord below the lesion and thus promote functional recovery,
and on the other hand will result in pathological symptoms. These changes can occur at both
anatomical and functional levels. However, due to the fact that more functional than anatom‐
ical data are available, for some receptors only functional changes have been reported. So far
5-HT receptors that have been confirmed to undergo anatomical changes include, but are not
limited to, 5-HT1 and 5-HT2 receptor families. In some other receptors, functional (activity)
changes are indeed detected although there are no data revealing their anatomical changes.
This group of receptors includes 5-HT3 and 5-HT7 receptors. So far there are no reports as to
the anatomical or functional changes for 5-HT4, 5-HT5, and 5-HT6 receptors following SCI.
Below I will mainly describe the 5-HT receptors that have been clearly demonstrated to
undergo anatomical and/or functional changes in relation to their impact on motor outputs.
4.1. 5-HT1 receptors
Among the different 5-HT1 subfamilies, 5-HT1A receptors were mostly investigated in terms
of their anatomical and functional changes probably due to their direct involvement in
functional recovery following SCI. For other subfamilies, such as 5-HT1B, 1D, and 1F, related
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studies were less abundant and results relating to their roles in motor functional outputs were
also less conclusive.
5-HT1A receptors: Using autoradiography, the expression of 5-HT1A receptors have been
shown to increase in the rat spinal cord 3 weeks following destruction of descending seroto‐
nergic fibers with 5,7-dihydroxytryptamine [83]. In cats, using the same technique, it was
found that after spinal cord transection at T13 level binding density was significantly in‐
creased in laminae II, III, and X of lumbar segments at 15 and 30 days, but at 60 days the binding
density recovered to the control level [28]. It should be addressed that using binding techni‐
que it is difficult to differentiate whether the labeled profiles were from neuronal cell bodies,
their dendrites or axon fiber terminals. Using immunohistochemistry with two different 5-
HT1A antibodies, one labeling neuronal somata and the other labeling the axon initial
segments, Otoshi et al. [31] reported that 8 weeks following complete spinal transection at T7-
T8 level the expression of 5-HT1A receptors in axon hillock was increased in laminae III, IV,
VII, and IX, whereas the expression in neuronal somata and dendrites were increased in
laminae VII and IX. This upregulation, both in the axon hillock and neuronal somata and
dendrites, was dependent on the sensory input since the receptors were not upregulated when
the spinal cord was isolated. Using in situ hybridization, Cornide-Petronio et al. [170] saw a
similar upregulation time course for 5-HT1A receptors in lampreys as in cats. They reported
an acute upregulation of 5-HT1A receptors in the spinal cord after SCI both in the rostral and
caudal part of the lesion site, and the upregulation recovered to normal levels at 3 weeks. This
quick recovery of 5-HT1A receptor expression may be due to that in lamprey serotonergic
descending projecting neurons in the rhombencephalon could regenerate their axons across
the lesion site after complete spinal cord transection [171]. Thus, the variation of results from
these studies may partly reflect the different receptor responses to SCI in different species.
There is ample evidence that the activation of 5-HT1A receptors could induce motor func‐
tional recovery after SCI [13, 84, 172]. Antri et al. [13] found that, in thoracic spinal cord
transected rats, after daily systemic application of 5-HT1A receptor agonist 8-OH-DPAT,
locomotor function was significantly improved when compared with control spinalized
animals. The agonist had both short- and long-term effects for motor functional improve‐
ment. A similar result was also demonstrated by Jackson and White [84] that in acute C1 spinal
cord transected rats, after intravenous administration of 8-OH-DPAT, the excitability of spinal
motoneurons was markedly enhanced. However, local application of 8-OH-DPAT directly
into the ventral horn by microiontophoresis inhibited the glutamate-evoked firing of moto‐
neurons. These results indicate that when 8-OH-DPAT was directly applied into the vicinity
of the motoneurons it may activate 5-HT1A receptors in the axon hillock which inhibits the
motoneuron firing [81]. However, the marked increase in firing of motoneurons induced by
systemic administration of 8-OH-DPAT suggests that 5-HT1A receptors in other locations,
likely at sites presynaptic to the motoneurons, have also been activated. In addition to the
functions described above, 5-HT1A receptors have been reported to increase bladder capaci‐
ty under saline or acid infused conditions in SCI cats [173].
5-HT1B receptors: In comparison with 5-HT1A receptors, studies concerning plastic changes
of 5-HT1B receptors following SCI are sparse. Using autoradiography, Laporte et al. [83]
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reported that when descending serotonergic projections were destroyed by 5,7-dihydroxy‐
tryptamine the labeling of 5-HT1B receptors was decreased (−12%) in the dorsal horn at the
cervical but not at the lumbar level in rats. Interestingly, when noradrenergic systems had been
lesioned by DSP-4 (N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine) there was an increase of
labeling of 5-HT1B receptors both at the cervical level (+31%) and the lumbar level (+17%). In
a C2 hemisection rat model, using quantitative RT-PCR, Mantilla et al. [86] did not detect
expression changes of 5-HT1B receptors in phrenic motoneurons 2 or 3 weeks following the
injury.
Similar to their functions in normal physiological states, in SCI states 5-HT1B receptors also
play an inhibitory role for motor outputs possibly through inhibitions on both mono- and
polysynaptic reflexes. In acute C1 spinalized rats, Honda et al. [174] showed that serotoner‐
gic depression of monosynaptic reflex transmission induced by application of 5-HTP was
mediated by 5-HT1B receptors. In S2 spinal cord transection model (also called tail spasticity
model), Murray et al. [99] showed that polysynaptic EPSPs that trigger muscle spasms after
SCI were inhibited by 5-HT1B receptors.
5-HT1D and 1F receptors: To my knowledge, no studies have investigated the expression
changes of these two receptors following SCI. Functionally, the activation of 5-HT1D recep‐
tors seemed to reduce sensory transmission in both monosynaptic and polysynaptic reflexes
in humans [95], and to inhibit bladder activity in cats after SCI [175]. The activation of 5-HT1F
seemed to inhibit long polysynaptic reflexes in rats after SCI [99]. However because the
agonists used in these studies were not specific enough for selected receptors the results were
not conclusive.
4.2. 5-HT2 receptors
5-HT2, especially 5-HT2A and 2C, receptors are the most intensely studied receptors among
all 5-HT receptor families mostly due to their considerable effects on the motor functional
recovery and perhaps also on the pathological symptoms developed following SCI such as
spasticity. Due to the close relationship and similar functions of these three receptor subfami‐
lies, their influences on the motor outputs after SCI will be described together.
5-HT2A receptors: Using different SCI animal models such as contusion, hemisection, and
complete spinal transection, it is confirmed that 5-HT2A receptors underwent different
degrees of plastic changes following SCI. In thoracic contusive rats using immunohistochem‐
istry, Lee et al. [30] found a moderate yet significantly increased 5-HT2A receptor expres‐
sion (~1.2-fold of control) in the motoneurons at L5-L6 level after 4 weeks of injury. With the
same method in a C2 hemisection rat model Fuller et al. [29] demonstrated a significant
upregulation (~1.7-fold of control) of 5-HT2A receptors in the ipsilateral phrenic motoneur‐
ons after 2 weeks of injury. In a S2 spinal transection model, Kong et al. [32, 33] reported a
dramatic increase of 5-HT2A receptor immunoreactivity (~5.6-fold of control) in the moto‐
neurons below the lesion. The upregulation began as early as 1 day after injury, reached a
maximal level by 28 days and lasted at least until 60 days, the longest time interval investi‐
gated. Similarly an upregulation of 5-HT2A receptors were also observed in chronic (6 weeks)
thoracic spinal transected rats. Navarrett et al. [35] reported a ~1.3-fold increase of 5-HT2A
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receptor mRNAs in the spinal tissue (including both white and gray matter) below the lesion
with RT-PCR. Upregulation of 5-HT2A receptor mRNAs was also reported in mice subject‐
ed to an acute thoracic spinal transection. Thus, Ung et al. [176] found that 3 h after the lesion 5-
HT2A receptor mRNA expression levels were increased 2.5-fold in the lateral intermediate
zone in L1-L2 segments and they remained to be elevated for at least 2 weeks. However, no
significant change was found in the ventral horn motoneuron regions, which was strikingly
different from that in the rat.
5-HT2B receptors: No expression changes have been reported for this receptor subfamily in the
spinal cord following SCI. With microarray global gene analysis technique, Wienecke et al.
[122] did not detect significant changes of 5-HT2B receptor mRNAs in S2 spinal transected rats.
5-HT2C receptors: Similar to 5-HT2A receptors, 5-HT2C receptor expression changes have been
investigated in different SCI animal models with different techniques. However, discrepan‐
cies exist as to whether 5-HT2C receptors are upregulated or not following SCI. In chronic SCI
rats (~15 weeks) severe contusion or transection at thoracic level (T9) could induce a signifi‐
cant increase of 5-HT2C receptor immunoreactivity in lumbar spinal cord [22]. The increase
could reach 4–7-fold in the ventral horn and ~17-fold in the dorsal horn over control level. In
thoracic (T8-T9) spinal transected neonatal rats, following 4 weeks injury 5-HT2C receptor
immunoreactivity was seen to increase 4–5-fold both in the spinal dorsal and ventral horn
[177]. In a S2 spinal transection rat model, data from our group [36] indicated that 5-HT2C
receptor immunoreactivity increased in all parts of the spinal gray matter below the lesion
from 2 weeks but did not reach a significant level until 3 weeks (~1.4-fold over control animals).
The increase sustained thereafter and a maximal level was reached at 45 days (~1.7-fold) and
maintained at 60 days, the longest investigated interval. It is somehow perplexing that
although upregulation was observed at protein level no significant increase at mRNA level
was detected in different SCI animal models [34, 35, 122, 178]. However, although no signifi‐
cant changes of the total amount of 5-HT2C receptor mRNAs were detected, Murray et al. [34]
did detect certain constitutive isoforms, such as INI isoform, that were significantly in‐
creased in the motoneurons 6 weeks after S2 spinal transection.
Functional significance for motor outputs of 5-HT2 receptors: The activation of 5-HT2 receptors has
different effects on motor outputs after SCI, which include promoting motor functional
recovery and causing maladaptive pathological motor symptoms such as spasticity. Due to
uncertainty of the expression of 5-HT2B receptors in the spinal cord most studies have been
focused on 5-HT2A and 2C receptors. There is ample evidence for the roles of 5-HT2A and
2C receptors in motor functional recovery following SCI from different studies (e.g., [9, 12, 14,
34, 43, 84, 134, 176, 179, 180], for reviews see [44, 45]). For example, in thoracic spinalized cats,
when a 5-HT2A/C receptor agonist (e.g., quipazine or DOI) was administrated α-motoneur‐
on excitability was increased and hindlimb motor activity was enhanced [9]. Similar results
were also demonstrated in SCI rats [12, 14] and mice [176]. Although 5-HT2A and 2C recep‐
tors both play a common role for motor functional recovery each subfamily may also exert
different functions in different aspects of the motor outputs. Using different agonists and
antagonists specific for each of these two receptor subfamilies it is found that 5-HT2A receptors
might contribute to locomotor network activation and locomotor-like movement generation
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[15, 43, 176]. Direct stimulation of 5-HT2C receptors with its agonist meta-chlorophenylpiper‐
azine improved weight-supported locomotion in adult rats spinalized as neonates [177, 181].
5-HT2C, probably also 2B, but not 2A, receptors could become constitutively active which
could contribute to motor functional recovery following SCI [34, 182].
One maladaptive consequence for 5-HT2 receptor plastic changes is the induction of muscle
spasm due to increased motoneuron excitability. The rapid and robust upregulation of 5-HT2A
receptors in spinal motoneurons might be responsible for 5-HT supersensitivity after SCI [32,
33]. Activation of 5-HT2C receptors could induce long-lasting reflexes of motoneurons in the
in vitro spinal cord preparations [134, 135]. These long-lasting reflexes could be enhanced
when 5-HT2C receptors became constitutively active following SCI [34, 182]. One of the cellular
mechanisms for the increased motoneuron excitability is that the activation of 5-HT2 recep‐
tors could enhance calcium and/or sodium persistent inward currents [42, 183].
In addition to promoting locomotion, 5-HT2 (especially 2A) receptors also play a significant
role for respiratory functional recovery after cervical spinal hemisection [179] and in enhanc‐
ing bladder function in thoracic spinal transected rats [184].
It should be addressed that the upregulation of 5-HT2 receptors does not by all means lead
the motoneurons toward a hyperexcitatory state. Recently one interesting finding is present‐
ed by Bos et al. [185] who showed that the activation of 5-HT2A receptors could increase K(+)-
Cl(–) cotransporter (KCC2) expression on cell membrane in the spinal cord motoneurons after
SCI. The upregulation of KCC2 receptors in turn increased the activity of GABA A and glycine
receptors which would restore endogenous inhibition and reduce spasticity after SCI in rats
[186]. These results indicate that the upregulation of 5-HT2A receptors would not simply
produce an excitatory effect. Rather, their activation will trigger an inhibitory factor which
attempts to balance the excitatory effect. This effect seems to be paradoxical to the 5-HT2A
receptors’ direct excitatory effect on motoneurons. However, this might be one of the com‐
mon functional mechanisms of a spinal network—different factors interact and compensate
each other, and the final motor output is determined by a summed vector of these push-pull
forces acted on the motoneurons. In fact, any motor action cannot be arisen solely from the
activation of a single factor; instead it needs a concert activity of multiple factors including
both excitatory and inhibitory. For instance, Hayashi et al. [22] have showed that in contu‐
sive SCI rats, application of 5-HT1A or 5-HT2C receptor agonists alone or in combination could
not improve hindlimb motor function; rather, motor functional improvement could be
achieved only when the 5-HT precursor 5-HTP was administrated, indicating that simultane‐
ously multiple 5-HT receptor activations are needed for motor functional recovery. This
concept is reinforced by the results from Noga et al. [16] who showed that in paralyzed,
decerebrated cats, when locomotion was induced by electrical stimulation of the mesence‐
phalic locomotor region, most locomotor-activated cells, labeled with c-Fos, colocalized with
5-HT1A, 5-HT2A, and 5-HT7 receptors in laminae VII and VIII in the thoracolumbar spinal
region.
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4.3. 5-HT3 receptors
There are no data demonstrating the expression changes of 5-HT3 following SCI. Laporte et
al. [83] did not detect 5-HT3 receptor expression changes with binding technique in rat spinal
cords whose descending serotonergic projections had been destroyed by 5,7-dihydroxytrypt‐
amine. However, lesions in peripheral nerves could reduce 5-HT3 receptor expression in the
spinal motoneurons in rats [187].
Most studies concerning 5-HT3 receptor functions have been focused on sensory aspects,
especially nociception. Studies relating to their functions in motor outputs after SCI are scarce.
So far there is only one study having investigated the influence of the activation of 5-HT3
receptors on motor outputs in SCI mice. In this study, Guertin and Steuer [152] showed that
in hindlimb paralyzed mice 5-HT3 receptor agonist SR-57227 could produce hindlimb
movements although with a low score. This result, anyhow, provided the first evidence that
5-HT3 receptors could modulate spinal motoneuron activity after SCI.
4.4. 5-HT7 receptors
So far there are no data available with respect to the expression changes of 5-HT7 receptors
following SCI. However, the activation of 5-HT7 receptor has been shown to be related to
locomotor functional recovery in SCI states [23, 43, 172]. Landry et al. [172] showed that in
thoracic spinal transected mice systemic application of 8-OH-DPAT, an agonist for both 5-
HT1A and 5-HT7 receptors, acutely induced hindlimb movements with characteristics similar
to normal locomotion. When the animals were pretreated with SB-269970, a selective 5-HT7
receptor antagonist, 8-OH-DPAT-induced movements were reduced. Sławińska et al. [23]
showed that, in thoracic spinal transected rats, grafting of neurons from the B1, B2, and B3
descending 5-HT system from the brainstem into the spinal cord below the lesion effectively
restored coordinated plantar stepping, and the application of SB-269970 disrupted the inter-
and intralimb coordination. Further evidence from the same group indicated that 8-OH-DPAT
facilitated plantar stepping in chronic spinalized rats [43]. Since 5-HT7 receptor agonists
mainly improved coordination movement the authors assumed that 5-HT7 receptors mainly
facilitated the activity of the central pattern generator interneurons. This assumption is
supported by anatomical data that 5-HT7 receptors were mainly expressed in the neurons in
the dorsal horn and the intermediate zone of the spinal gray matter [16]. In addition to the
effects on locomotion, it has been reported that the activation of 5-HT7 receptors by their
agonist LP44 (4-[2-(methylthio)phenyl]-N-(1,2,3,4-tetrahydronaphthalen-1-yl)-1-piperazine‐
hexanamide) increased bladder voiding efficiency in chronic thoracic spinal transected rats
[188].
5. Plasticity of 5-HT innervations after SCI
It is evidenced that a small number of 5-HT receptors, or more precisely receptor isoforms,
could become active following SCI without ligand activation—so-called constitutive activa‐
tion. However, for most of the 5-HT receptors that do not have constitutive isoforms the
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presence of their ligand—5HT is a necessity for their activation. Then, where could 5-HT
originate following SCI? After contusion spinal cord injury or partial spinal cord transec‐
tions there are still spared supraspinal serotonergic projections and these serotonergic fibers
could undergo plastic changes to eventually supplement lost 5-HT supply in the injured spinal
cord. For example, in contusion injury the density of spared 5-HT fibers below the lesion varies
depending on the locations along the dorsoventral axis and the severity of the injury [22, 189,
190], and 5-HT innervation could be partially restored with time which is responsible at least
partly for motor functional recovery [190]. In thoracic hemisection injury, the density of 5-HT
fibers in the ipsilateral ventral horn varied from 8% to 30% of the control value according to
studies with a postinjury interval 4–7 days [39, 191–194]. The data are inconsistent as to
whether 5-HT fibers increase with time following hemisection. Some researchers reported a
gradual increase of 5-HT fibers on the ipsilateral side below the lesion (e.g., [193, 195]), whereas
some others did not see apparent changes (e.g., [39, 194]). For example, Saruhashi et al. [193]
observed that 5-HT-immunoreactive fibers recovered from 20% to about 75% of the normal
value in the ventral horn during first 4 weeks. Camand et al. [195] also reported a similar
finding in the intermediate zone. However, Filli et al. [194] reported a decrease to about 10%
by 4 weeks from about 30% at day 4 in ventral horn motoneuron region. Azam et al. [39]
reported that by 60 days the density of 5-HT-immunoreacitve fibers in the intermediate zone
was reduced to 11% from 23% at 5 days, whereas in the ventral horn it was not reduced (23%
vs. 22%). Following complete spinal transection, some 2–15% of the normal content of 5-HT
remained in the spinal cord below the lesion ([196]; for review see [25]).
The next question would be then where the residual 5-HT originates following complete spinal
transection. One origin might be the intraspinal serotonergic neurons. However, intraspinal
serotonergic neurons are very few in number and sparsely distributed (see Section 1). Then,
what are the other possible sources? Recent findings from our [38] and Bennett’s group [37]
indicated that AADC cells in the spinal cord might be another origin. AADC is an essential
enzyme for the synthesis of 5-HT, dopamine, and certain trace amines from their respective
precursors. AADC cells are widely distributed in different regions of the spinal cord [38], not
limiting to the area around the central canal as reported previously [197]. Following SCI the
ability of AADC cells in the spinal cord to synthesize 5-HT/dopamine from 5-HTP/L-dopa was
dramatically increased and 5-HT/dopamine produced in the AADC was responsible for the
increased motoneuron ability recorded both in vivo and in vitro [37, 38, 40, 198]. Nonethe‐
less, we have to admit that without 5-HTP application 5-HT could not be detected in the spinal
AADC cells. This might be due to that the detecting techniques used in related studies were
not sensitive enough to disclose a small amount of 5-HT, or the turnover rate of 5-HT produced
in the AADC cells was so high that once produced it was immediately metabolized. One piece
of evidence to support the speculation that monoamine transmitters could be produced from
AADC cells in the spinal cord after SCI comes from Hou et al. [199], who showed that the
number of dopamine-producing cells, which contained both AADC and tyrosine hydroxy‐
lase, was increased in lumbosacral spinal cord in thoracic spinal transected rats; and with
enzyme-linked immunosorbent assay (ELISA) dopamine with a content of about 10% of its
normal value could be detected in this part of the spinal cord even without L-dopa applica‐
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tion. At the same time they also showed that dopamine produced from the spinal cord below
the lesion was implicated for micturition functional recovery following SCI.
6. Conclusions
The serotonin system in the spinal cord is an important modulator for sensory, motor as well
as autonomic function. This system normally exercises its function via the interaction between
ligand 5-HT and a number of 5-HT receptors expressed in different structures in the spinal
cord. Among the 14 5-HT receptor subfamilies at least 12 have been detected in the spinal cord,
in which 5-HT1A, 2A, 2C, and 7 receptors have been demonstrated to be more important for
motor control. In normal physiological states, these receptors coordinate with each other and
also with other monoamine systems to enable smooth and controllable motor outputs for our
physical activity [200]. Following SCI extensive plastic changes occur for a number of 5-HT
receptor subfamilies, mostly with increased receptor numbers and/or constitutive activity. In
addition, plasticity also occurs for descending serotonergic fibers (in the case of incomplete
SCI) and intraspinal serotonin-producing cells. The coeffects of these plastic changes, togeth‐
er with the plastic changes of other monoamine systems, ultimately lead to increased moto‐
neuron excitability in the chronic phase [17, 21, 108]. These plastic changes have both beneficial
and detrimental effects for spinal motor outputs after SCI. Although the plastic changes can
result in an adaptive compensation of the lost transmitters and thus assist in motor function‐
al recovery, they can also result in a plethora of maladaptive problems, such as spasticity. In
clinical practice, a strategy needs to be set so as to maximally take advantage of the positive
side of the plasticity to promote motor functional recovery and meanwhile to reduce nega‐
tive effects to a minimal extent. To reach this endpoint, pharmacological and/or genetic
interferences need to be utilized so that the activity of different 5-HT receptors and 5-HT supply
in the spinal cord reach a new balance and consequently an appropriate motor behavior is
generated. Such a strategy would certainly have great implications for future treatment of SCI
patients.
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